GPCR 2012 Conference Speakers: Over 30 Leading International GPCR Experts from Industry and Academia

GPCR 2012 Conference Speakers: Over 30 Leading International GPCR Experts from Industry and Academia

Graeme Milligan Professor of Molecular Pharmacology University of Glasgow, UK

Roger K. Sunahara, Associate Professor of Pharmacology, University of Michigan Medical School, USA

Ad P. IJzerman, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands

75% NEW Speakers for GPCRs 2012 discussing the next wave of commercially viable GPCR research including:

• Mark Dowling, Research Investigator III, Receptor Biology, Novartis Pharmaceuticals UK Limited, UK
• Stephen Hunt III, Chief Scientific Officer, Anchor Therapeutics, Inc. USA
• Sonia Poli, Head of CNS and Non-Clinical Development, Addex Pharma SA, Switzerland
• Christopher J. Langmead, Head of Pharmacology, Heptares Therapeutics Ltd, UK
• Thomas P. Sakmar, Laboratory of Molecular Biology & Biochemistry, The Rockefeller University, USA
• So Iwata, David Blow Chair of Biophysics, Imperial College London, UK 
• Jerome Bernard, Director, EuroscreenFAST Business Unit, Euroscreen S.A. Belgium
• Gayathri Swaminath, Senior Scientist, Amgen, Inc. USA
• Andrew B. Tobin, Department of Cell Physiology and Pharmacology, University of Leicester, UK
• Teresa Bennett, VP Research, Vivia Biotech, Spain
• Christopher A Reynolds, Department of Biological Sciences, University of Essex, UK
• Mark Wheatley, Chair of Biochemical Pharmacology, University of Birmingham, UK